TOCCA Life Holdings, Inc. (OTCMKTS: TLIF) Addiction and the FDA

TOCCA Life Holdings, Inc. (OTCMKTS: TLIF) Addiction and the FDA

TOCCA EXPANDS ITS REACH FOR FDA APPROVAL BY DEVELOPING THE FIRST EVER DRUG TESTING TOOL KIT THAT OFFERS PARENTS FREE MEMBERSHIP TO INSTRUCTIONAL ADVICE, VIDEO DEMONSTRATIONS AND MOST IMPORTANTLY, A NON-EVASIVE, NO CONTROVERSIAL ABILITY TO START THE PROCESS FOR HOME AND WORKPLACE DRUG ACCOUNTABILITY.

TOCCA Life Holdings, Inc. (OTC Pink: TLIF) announced that they are ready to change up the industry of addiction by helping the family first and before the rampant selling bestowed upon the potential client. Instead of engaging in the current industry to sell the client for the immense profit margins that have hurt client care, TOCCA has remained nearly anonymous working on solutions during a quiet stay of watching the industry. The company has now created what may be considered the most organized client care pipeline of future business, simply by helping families first.

TOCCA is expanding the reach for FDA approval, for the first ever Drug Testing Tool Kit after years of experience, thousands of stories from clients and continued sales of individual products via TOCCALife.com and https://drugtestkits.toccalife.com. The kit is being set for mass market retail to change the way business is done. It focuses on family accountability first and before acceptance of client care. It is a “wake up call” to the industry and families. Business success expects to be eminent, however family support is the key element before, during and after, any type of client care.

TOCCA Life Holdings, Inc. CEO, Tyler Cornell explains, “$50 Million in cash payments at a cost of $49.95 exemplifies a willingness to learn by the family of the client. That should start us with a pipeline of nearly 1 Million potential clients for our core business. It creates an interactive relationship with the professionals of TOCCA long before the first intervention and a pipeline of steady revenue streams to invest into client care. It is one of the few ever product sales that have an “upsell” of client care at exponentially higher revenues than that the product sale. It is an active attempt to help families and potential clients from the disease of addiction With client care and shareholders as the utmost priority, it is expected that TOCCA has developed the first attempt, within the 80 year old plus industry, to help people practice prevention while securing shareholders interests by formalizing its efforts in the homes of others. The effort is a way for people to become active in the lives of others by using the TOCCA SCREEN Drug Testing Tool Kit. A way to help instead of being sold; A way to educate before, during and after intervention. It is a better slogan than, “Just Say No” but instead, a process to help eliminate the demand for drugs and the $650 Billion war against it. It helps take the mystery out of the disease.”

TOCCA contends the reach of their new drug testing tool kit will excite the FDA, insurance companies and the public. It encompasses the needs of the public to start accountability within their own homes and balance the scales on multiple levels of the drug and drug rehabilitation industry with one swift movement. Included in the kit, along with available video demonstrations and instructional information, TOCCA SCREEN Drug Testing Tool Kit will include a non-invasive surface drug test. The test will allow parents and employers to test for the presence of pills and drugs on everything from a wallet to a desk or a cell phone to a company vehicle before the parents or employers confront the potential victim suffering from The Other Cancer Called Addiction.

Cornell continued, “TOCCA is a way of life everyone should appreciate. Society needs to help from the day before The Other Cancer Called Addiction is triggered upon its victim to the 7 months after they need clothes for their interview. Accountability within the home and work place using our professional methodology with our professional products is a great staging point to minimize the demand for drugs which cost taxpayers Hundreds of Billions of Dollars per year. We are setting the stage and we invite everyone to help us, help you.”

The following two tabs change content below.
Shayne Heffernan Funds Manager at HEFFX holds a Ph.D. in Economics and brings with him over 25 years of trading experience in Asia and hands on experience in Venture Capital, he has been involved in several start ups that have seen market capitalization over $500m and 1 that reach a peak market cap of $15b. He has managed and overseen start ups in Mining, Shipping, Technology and Financial Services.

Latest posts by Shayne Heffernan (see all)

You must be logged in to post comments :  
CONNECT WITH